Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions

被引:1
作者
Galea, Roberto [1 ]
Raeber, Lorenz [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland
关键词
left atrial appendage closure; antithrombotic therapy; drug regimen; device related thrombus; WATCHMAN DEVICE; COMPUTED-TOMOGRAPHY; ORAL ANTICOAGULANTS; CLINICAL-OUTCOMES; FIBRILLATION; OCCLUSION; SAFETY; WARFARIN; EFFICACY; STROKE;
D O I
10.31083/j.rcm2412343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Percutaneous left atrial appendage closure (LAAC) has been established in clinical practice as an attractive alternative to oral anticoagulation for preventing stroke in patients with atrial fibrillation and high bleeding risk. The devices approved in Europe and United States (US) for percutaneous LAAC contain metal and antithrombotic therapy is strongly recommended after their implantation to prevent apposition of thrombus on the atrial surface of the device during endothelialization. However, there is still uncertainty regarding the optimal antithrombotic drug regimen following device implantation in view of the incomplete understanding of the LAAC device healing process, the lack of randomized clinical trials comparing different antithrombotic agents after LAAC and the heterogeneous bleeding risk of patients undergoing LAAC. Thus, this review aims to evaluate the available evidence and the remaining challenges related to the postLAAC antithrombotic regimens. Furthermore, common clinical scenarios associated with challenging management of antithrombotic therapy after LAAC and potential future directions, will be discussed.
引用
收藏
页数:13
相关论文
共 57 条
[1]   Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion Insights From the NCDR LAAO Registry [J].
Alkhouli, Mohamad ;
Du, Chengan ;
Killu, Ammar ;
Simard, Trevor ;
Noseworthy, Peter A. ;
Friedman, Paul A. ;
Curtis, Jeptha P. ;
V. Freeman, James ;
Holmes, David R. .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2022, 8 (06) :766-778
[2]   Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion A Meta-Analysis [J].
Alkhouli, Mohamad ;
Busu, Tatiana ;
Shah, Kuldeep ;
Osman, Mohammed ;
Alqahtani, Fahad ;
Raybuck, Bryan .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2018, 4 (12) :1629-1637
[3]   Acute, periprocedural and longterm antithrombotic therapy in older adults 2022 Update by the ESC Working Group on Thrombosis [J].
Andreotti, Felicita ;
Geisler, Tobias ;
Collet, Jean-Philippe ;
Gigante, Bruna ;
Gorog, Diana A. ;
Halvorsen, Sigrun ;
Lip, Gregory Y. H. ;
Morais, Joao ;
Navarese, Eliano Pio ;
Patrono, Carlo ;
Rocca, Bianca ;
Rubboli, Andrea ;
Sibbing, Dirk ;
Storey, Robert F. ;
Verheugt, Freek W. A. ;
Vilahur, Gemma .
EUROPEAN HEART JOURNAL, 2023, 44 (04) :262-279
[4]  
Andreotti F, 2013, REV ESP CARDIOL, V66, P79, DOI [10.1016/j.rec.2012.09.011, 10.1016/j.recesp.2012.09.013]
[5]   Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure [J].
Asmarats, Lluis ;
O'Hara, Gilles ;
Champagne, Jean ;
Paradis, Jean-Michel ;
Bernier, Mathieu ;
O'Connor, Kim ;
Beaudoin, Jonathan ;
Junquera, Lucia ;
Del Val, David ;
Muntane-Carol, Guillem ;
Cote, Melanie ;
Rodes-Cabau, Josep .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (08) :E009039
[6]   Transcatheter Occlusion of the Left Atrial Appendage-experimental Testing of A New Amplatzer Device [J].
Bass, John L. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (02) :181-185
[7]   Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial [J].
Boersma, Lucas V. ;
Ince, Hueseyin ;
Kische, Stephan ;
Pokushalov, Evgeny ;
Schmitz, Thomas ;
Schmidt, Boris ;
Gori, Tommaso ;
Meincke, Felix ;
Protopopov, Alexey Vladimir ;
Betts, Timothy ;
Foley, David ;
Sievert, Horst ;
Mazzone, Patrizio ;
De Potter, Tom ;
Vireca, Elisa ;
Stein, Kenneth ;
Bergmann, Martin W. .
HEART RHYTHM, 2017, 14 (09) :1302-1308
[8]   Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry [J].
Boersma, Lucas V. A. ;
Schmidt, Boris ;
Betts, Timothy R. ;
Sievert, Horst ;
Tamburino, Corrado ;
Teiger, Emmanuel ;
Pokushalov, Evgeny ;
Kische, Stephan ;
Schmitz, Thomas ;
Stein, Kenneth M. ;
Bergmann, MartinW. .
EUROPEAN HEART JOURNAL, 2016, 37 (31) :2465-2474
[9]   Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study [J].
Chugh, Sumeet S. ;
Havmoeller, Rasmus ;
Narayanan, Kumar ;
Singh, David ;
Rienstra, Michiel ;
Benjamin, Emelia J. ;
Gillum, Richard F. ;
Kim, Young-Hoon ;
McAnulty, John H. ;
Zheng, Zhi-Jie ;
Forouzanfar, Mohammad H. ;
Naghavi, Mohsen ;
Mensah, George A. ;
Ezzati, Majid ;
Murray, Christopher J. L. .
CIRCULATION, 2014, 129 (08) :837-847
[10]   Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study [J].
Cresti, Alberto ;
Angel Garcia-Fernandez, Miguel ;
Sievert, Horst ;
Mazzone, Patrizio ;
Baratta, Pasquale ;
Solari, Marco ;
Geyer, Alessia ;
De Sensi, Francesco ;
Limbruno, Ugo .
EUROINTERVENTION, 2019, 15 (03) :E225-E230